Annual Total Expenses
$2.90 B
+$312.97 M+12.10%
December 31, 2022
Summary
- As of February 7, 2025, HZNP annual total expenses is $2.90 billion, with the most recent change of +$312.97 million (+12.10%) on December 31, 2022.
- During the last 3 years, HZNP annual total expenses has risen by +$1.74 billion (+149.40%).
Performance
HZNP Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Expenses
$804.12 M
+$8.05 M+1.01%
June 30, 2023
Summary
- As of February 7, 2025, HZNP quarterly total expenses is $804.12 million, with the most recent change of +$8.05 million (+1.01%) on June 30, 2023.
- Over the past year, HZNP quarterly total expenses has increased by +$72.44 million (+9.90%).
Performance
HZNP Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
HZNP Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.1% | +9.9% |
| 3 y3 years | +149.4% | +89.2% |
| 5 y5 years | +111.1% | +175.1% |
HZNP Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -10.8% | at high | -14.1% |
| 5 y | 5-year | at high | -59.9% | at high | -61.6% |
| alltime | all time | at high | -99.4% | at high | -99.5% |
Horizon Therapeutics Public Limited Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $804.12 M(+1.0%) |
| Mar 2023 | - | $796.07 M(+8.9%) |
| Dec 2022 | $2.90 B(+12.1%) | $730.85 M(-2.0%) |
| Sep 2022 | - | $745.75 M(+1.9%) |
| Jun 2022 | - | $731.68 M(+5.9%) |
| Mar 2022 | - | $690.93 M(-6.8%) |
| Dec 2021 | $2.59 B(+58.2%) | $741.71 M(+5.7%) |
| Sep 2021 | - | $701.45 M(+0.8%) |
| Jun 2021 | - | $696.03 M(+42.0%) |
| Mar 2021 | - | $490.05 M(+14.0%) |
| Dec 2020 | $1.63 B(+40.6%) | $429.76 M(+5.4%) |
| Sep 2020 | - | $407.85 M(-4.0%) |
| Jun 2020 | - | $424.92 M(+14.1%) |
| Mar 2020 | - | $372.40 M(+20.6%) |
| Dec 2019 | $1.16 B(-0.4%) | $308.87 M(+7.7%) |
| Sep 2019 | - | $286.85 M(+0.8%) |
| Jun 2019 | - | $284.57 M(+0.9%) |
| Mar 2019 | - | $282.17 M(-3.7%) |
| Dec 2018 | $1.17 B(-15.1%) | $292.91 M(+7.0%) |
| Sep 2018 | - | $273.83 M(-6.3%) |
| Jun 2018 | - | $292.28 M(-5.0%) |
| Mar 2018 | - | $307.53 M(+3.6%) |
| Dec 2017 | $1.37 B(+30.1%) | $296.88 M(-0.2%) |
| Sep 2017 | - | $297.40 M(-34.3%) |
| Jun 2017 | - | $452.90 M(+38.8%) |
| Mar 2017 | - | $326.24 M(-11.3%) |
| Dec 2016 | $1.06 B | $367.93 M(+60.0%) |
| Sep 2016 | - | $230.02 M(+1.8%) |
| Jun 2016 | - | $225.91 M(-2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $231.89 M(+12.3%) |
| Dec 2015 | $701.67 M(+129.7%) | $206.49 M(+14.2%) |
| Sep 2015 | - | $180.81 M(-12.2%) |
| Jun 2015 | - | $205.99 M(+90.1%) |
| Mar 2015 | - | $108.38 M(+14.3%) |
| Dec 2014 | $305.45 M(+161.4%) | $94.86 M(+8.9%) |
| Sep 2014 | - | $87.09 M(+19.0%) |
| Jun 2014 | - | $73.16 M(+45.3%) |
| Mar 2014 | - | $50.34 M(+40.4%) |
| Dec 2013 | $116.87 M(+19.6%) | $35.84 M(+33.5%) |
| Sep 2013 | - | $26.86 M(-0.3%) |
| Jun 2013 | - | $26.93 M(-1.1%) |
| Mar 2013 | - | $27.24 M(-2.7%) |
| Dec 2012 | $97.72 M(+68.6%) | $27.98 M(+10.9%) |
| Sep 2012 | - | $25.23 M(+13.7%) |
| Jun 2012 | - | $22.19 M(-0.6%) |
| Mar 2012 | - | $22.31 M(-3.6%) |
| Dec 2011 | $57.95 M(+25.6%) | $23.15 M(+45.4%) |
| Sep 2011 | - | $15.93 M(+58.0%) |
| Jun 2011 | - | $10.08 M(+14.8%) |
| Mar 2011 | - | $8.78 M(-30.3%) |
| Dec 2010 | $46.13 M(+145.5%) | $12.60 M(+2.5%) |
| Sep 2010 | - | $12.29 M(-9.7%) |
| Jun 2010 | - | $13.62 M(+78.7%) |
| Mar 2010 | - | $7.62 M(+43.2%) |
| Dec 2009 | $18.79 M(-30.1%) | $5.32 M(+18.0%) |
| Sep 2009 | - | $4.51 M(-5.6%) |
| Jun 2009 | - | $4.78 M(+14.2%) |
| Mar 2009 | - | $4.18 M |
| Dec 2008 | $26.87 M | - |
FAQ
- What is Horizon Therapeutics Public Limited annual total expenses?
- What is the all time high annual total expenses for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited annual total expenses year-on-year change?
- What is Horizon Therapeutics Public Limited quarterly total expenses?
- What is the all time high quarterly total expenses for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly total expenses year-on-year change?
What is Horizon Therapeutics Public Limited annual total expenses?
The current annual total expenses of HZNP is $2.90 B
What is the all time high annual total expenses for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual total expenses is $2.90 B
What is Horizon Therapeutics Public Limited annual total expenses year-on-year change?
Over the past year, HZNP annual total expenses has changed by +$312.97 M (+12.10%)
What is Horizon Therapeutics Public Limited quarterly total expenses?
The current quarterly total expenses of HZNP is $804.12 M
What is the all time high quarterly total expenses for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly total expenses is $804.12 M
What is Horizon Therapeutics Public Limited quarterly total expenses year-on-year change?
Over the past year, HZNP quarterly total expenses has changed by +$72.44 M (+9.90%)